FibroBiologics, Inc. (FBLG) Granted European Patent Covering Enhanced Fibroblast Therapies

FibroBiologics, Inc. was granted European Patent No. 3568465 for methods to enhance fibroblast therapeutic activity using platelet rich plasma and cytokines, with claims including angiogenesis and spinal disc regeneration.Material DetailsContext by AI AnalystThis is an early-stage IP expansion supp…